Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hey we actually agree on something. The I/C trial was a complete disaster. But I sure don't know anything about the alleged company and ex employee that were responsible for this disaster. I definitely know I have never heard any such thing except from you. Care to expand. Even IF that were the case, who would have hired this horrific company and incapable employee? Management? So again, they must be worse then I could ever have imagined. And what is the name of their replaced company or employee?
So I wanted to look into our CLI interim results and when we may see them.
If you look at their May 2017 presentation, they gave us an expected data readout from this trial 2h18/1H19. So this was their expected timeframe when they started enrolling in May.
Now jump to July, when the milestones were changed to 12 months and no mention of CLI interim results. Same thing with October's presentation. Sure 12 months from October wouldn't take them all the way to 2H18. But it is something to keep an eye on with future shareholder updates...presentations. Will have to wait until January's presentation to find out.
I have been on other conference called where the company gets asked how their trials are progressing. Numbers were given. It's a way to keep shareholders up to date. Omitting these critical numbers just leaves everyone in the dark. Unless that's where they want people to be, so they can do raises whenever they want.
So I will take Nov 18 as the earliest possible date a readout could happen. Maybe it will come back in November or Decembers presentations.
Become a management that is transparent to shareholders. Have the courage to face them in conference calls for once. If your missing some, you can have mine since I'm laughing them off all the time. The closer this gets to the end of the year with nothing, I think they will have to face the music and the calls for heads will increase dramatically. All justified for how they treat shareholders. Under 30 trading days left.
How many sites did the I/C trial have. How long did that take?
Usually that's what you do but thanks see a simple link, and all that goes away. But no matter what, they have to enroll 123. That's not going to be fast. Almost certainly not this year or mid next. But we will wait to hear anything from this company.
Where do you get 1 year? Please post a link to substantiate your claim. I just posted the measures and their timeframes. Most up to 36 months. Could be. But we don't know for sure. I'm still waiting for your first "watch and see" come true. You've been saying this for many many years and not one has come to fruition.
It sure seems that way sometimes EichKing. Management has truly mislead the longest of the longs like us. Correcting the many false statements and claims on this board, is easy, and I can vent a little. And it keeps me reading more on this company than ever before. Not that doing that is a good thing sometimes. One thing for sure, I hope my pessimistic views are wrong. Never wanted to be more wrong in my life, but nothing has shown otherwise yet.
Now we have claims that possibly they may stop CLI trials early because of great results. Possible, but unlikely imo. The two phase 1's enrolled 27 people. Of them, 4 had major events. Sure it's better than the statistical numbers they compare it to, but the numbers are small, so a little less significant. If we had 100% numbers, would be a little more likely...key word being little. The I/C trial wasn't stopped early. So the further advanced CLI may be harder.
Now as for the timeframe to get interim results. I can base it solely on previous trials. I think it will be some time to recruit 123 patients. We had a ton of sites for the I/C trial, and we all know how long that took. Some suggest a year after. Here's the measures from clinical trial website. Notice most are up to 36 months. Still waiting for Allo to post where they got one year from, but that will never happen. I don't know for sure what length follow up will be. What measures they will use, I don't know. Maybe complete wound healing would suffice. But No matter what, don't see anything until late 2019 at the earliest.
Primary Outcome Measures:
Time to major amputation or death (AFS) [ Time Frame: Up to 36 months from enrollment ]
Secondary Outcome Measures:
Time to first occurrence of any of the events (in index leg)-major amputation,revascularization due to worsening of CLI,doubling of total wound area from baseline,anew gangrene. All-cause mortality. [ Time Frame: Up to 36 months from enrollment ]
Time to major amputation of the index leg. [ Time Frame: Up to 36 months from enrollment ]
Complete wound healing in the index leg [ Time Frame: 12 months from enrollment ]
Ischemic pain (NRS). [ Time Frame: 6 months from enrollment ]
Time to adjudicated major amputation of the index leg or death [ Time Frame: Up to 36 months from
Now if people think we won't get more dilution early 2018 without partnership or government funding or stockpiling, so be it. Only trouble is if we do, price will be horrific. Again people want to think this scenario is impossible, nothing anyone can do to change their stubborn minds. It is a definite and scary possibility. The street keeps us here for a reason. A stock is only worth what one will pay for it, and they only offer less for them than we did 7 years ago. Pathetic!!! Some are new here, so it may take time. Others have changed just like we have. Keep the faith though. I still do.
You want to use that logic, CLI is a complete waste of time and effort.management is even dumber than I thought. You can't post a link because you made it up. LMBO. Show this dingbat please. LMBO Sometimes the spark just isn't there anymore.
No link EH? What a surprise. But again, even if they already enrolled 50% (LMBO) they are still waiting a year. And considering we really only have phase 1 numbers in human trials that have been completed with results, this is not a sure thing by any means. ARS is our only near term possibility PERIOD. There you go Happy, more unsubstantiated claims. But yes, they're amazing. Why would anyone talk about them that way. LMBO!!!
Care to provide a link? And even if that's the case, how long did it take I/C to enroll similar number to the 50%. Three years. So ya I'm the clueless one. You're doing your job well though. Throw out meaningless numbers and time frames to suit your employers needs.
Yes Happy, we may get interim results one day. But that's not going to bring us to marketing in the near term. And yes you post once 50% are done in CLI, results may lead to early marketing. Those 50%, would have to be followed for 3 years. Can't imagine things being otherwise after 6 months or a year. And if you look at the length of time the I/C trial to enroll, it gives you a realistic timeframe, not the twins or Allo. And just look at their post to me and you have your answer from earlier.
Care to expand. Nah just throw insults with absolutely nothing to back it up. There is a trade off with these smaller patient trials...longer timeframes. So go back to your Lonza pipe dreams and Efrat closing some deals. LMBO
Too thinly may be the operative word there Jasper. In CLI, the patients are followed for 3 years, so we have a while for that. Hip study, they are followed for a year. ARS...needs to start then I'd imagine 6 months to a year. Japan fast track is just a joke. So without a partnership with some cash, I don't see us making it to any finish line without serious dilution.
Hence the concern going to a ton of shows. Maybe they are anticipating something big and then want to promote it. Month and a half to year end. Hoping we get some clarity on something from them, not just the usual rehashing of stuff we already know. I/C results will be extremely important and better be clearly positive. Otherwise that casts serious doubts on CLI as well.
I am curious if anyone knows about the relationship between the CRO and company. Is there any divulgence to the company from say, the first 50 patients that go through the trial? Does Pluristem actually have any idea how these patients faired, or do they have to wait for all to be finished before the company sees the results. Would like to know if their "positive" remark could have any factual merit, or just they just hoping for that.
That is an excellent point Blue. I sure hope they wouldn't do that to their own. One thing I wish os that we could see ATM numbers. Who knows if/when/how many they did/continue to sell. It's horrible really. A company can dilute by almost half, and not have to report it for 3 months. We will be in the dark on that one until then. Unless of course they become transparent. Lmbo!!!
From the China article you just posted.
"SAFE spokeswoman Wang said the regulator would focus its attention on cross-border deals in real estate, hotels, entertainment, cinemas, and sports clubs."
If you actually read the article, it has nothing to do with companies like Pluristem. Just an excuse for not being able to get a deal closed. Someone had posted something a while back from the potential investor, that said it had nothing to do with new regulations, but their DD. Just found the link easily enough. But we should believe you right.
http://www.globes.co.il/en/article-chinas-innovative-medical-cancels-pluristem-investment-1001193556
And now they are sending Efrat. Guess since the twins can't close them, they'll let IR try and bang one out. LMBO.
Yes this is one show at least that I can understand the reason for attending. This paragraph was taken from 2016's summary of the show. Not sure if they're talking about Pluristem, but I hope so.
"One lecture which received a huge amount of attention was one on stem cell therapy, as this form of treatment is well on the way towards significantly changing the medical world. In subsequent discussions during the breaks, this topic was by far the most popular subject of the conversations."
10 years that's crazy. No wonder the tone of your posts. Rightfully so no matterz what some say. Until the end of the year is my last timeframe. Been waiting way too long for this to actually increase in price. It wasn't me that coined the twins, but there are other terms that would also fit well. Don't think I/H would allow. We can only wait and see what happens as always.
Just because we have COMPLETED a trial, doesn't mean it's successfol. Whether it's a Million subjects or 172.
Thanks EichKing,
People seem to forget our biggest study is 20 people for our phase 1/2 in hip fracture. We have NO evidence with any substantial numbers with humans. You can enjoy phase 3 trials starting, but in essence, they are with phase 2 numbers. Our results in the first actual study with some significant numbers will only come from the IC trial early next year.
So until we get those numbers from 172 subjects from I/C, we are in limbo imo. So until those numbers are released, we really are just a phase 2 at most, company when it comes to all else aside from ARS trial. Maybe that's the reason our price is where we are at. Just thought of that this evening unfortunately. Each phase eliminates a vast proportion of candidates, so until we get those results early next year, we will remain so. Unless ARS kicks in.
I have no idea. Just basing it on the upcoming deadline, and the check mark beside it in the presentation.
Unusually high volume on TASE for a Sunday and a 6.5% increase to boot. Did they actually close Sosei? That's my call this week. But would love to hear something better. Get us back close to the $2's!!!!
Upon looking further at the October presentation, I think you are right Blue. They show their share price of $1.97 as of Oct. 27th. Guess they didn't want to show post crash price on Oct. 31st which would be a more proper timeframe. We have known about the disappearing milestones for more than just a couple of weeks.
But there was one thing that caught my eye. On Page 18, they put check marks beside ALL of the subjects, including form joint venture. All of the checks have been accomplished except that one. Maybe it has now. They put checks on all completed things, and bullets for ones that aren't. In the expected milestones, 1 check for initiated CLI trial, and bullets for all else that aren't completed yet.
A missed correction from whoever made the presentation? Most likely. But maybe not. Unfortunately that is what shareholders are forced to do. Read tea leaves, look for hints and clues and innuendos, along with a million speculative thoughts which is all we can unfortunately do. Normal I guess for a company that keeps their shareholders in the dark. Abnormal for companies with real management, that want to promote their accomplishments and prospective possibilities. Trade shows and presentations for shareholder updates. That's all we get. An odd interview thrown in once in a while. How bout throwimg us a bone once in a while. Pathetic truly.
But maybe we will get that Sosei deal closed finally, and get the fast track PMDA trial underway before we cross the two year delay mark come Dec. 5th.
Hey Blue. October presentation has been here for some time. We are still waiting for our shareholder presentation, the November presentation to be released. LMBO at the twins incompetence.
Many here seem to think that this company follows many in the industry when it comes to raises. Of course they do. Limited financing options, expensive trials, extremely ling time roi. But many seem to forget the other norm in this industry. Dilute, dilute, dilute...reverse split. Yes just sit back calmly, they got the best technology, in great hands. Ya right.
Someone just posted an article talking about the possibilities with Pluristem and the possibilities when it comes to CLI. I tried looking for it but couldn't find it. It mentioned about a different CLI product that showed great potential in phase 2, but not in phase 3. There is an much increased risk, when it comes to phase 3 trials that nobody would want to think about. We have, in essence, a phase 1/2 trial in CLI, with no placebo control. All comparisons based on previous results from other studies.
There is a reason that phase 3 trial success is even harder to obtain successful results. There is next to no evidence, that any Pluristem phase 3 trials will give the results that everyone is wanting/expecting. That is why the success rate from 2 to 3 drops by a extremely large percentage. Nobody talks about that, just we have the best product...period! Not yet by any means, just great potential. And enormous risk, especially with the twin clowns running the ship.
Someone mentioned quite brilliantly, that this raise is the last at these levels. No way we will ever get a raise of that sort, if indeed we start dwindling the cash, going to these useless shows. Nobody is going to pony up anything in the $1's to watch them yet again, blow through cash like we have with the 30% dilution we had in one year, when expectations are so high, and deliverance is at a snails pace.
The "newbie" to the group states they "must" be a capable management team, or we wouldn't have been able to get us to where we are. Correct. They had a vision and took us to where we are. They have there place in history. But they are INCAPABLE of getting us to the next level. Same dang level for 7 years when it comes to stock price. Sure progression in trials etc is great. That's what companies do. But to just keep diluting to get us to this stage, puts a bad taste in people's mouths who have just invested a large sum of money into this stock like they did pre-raise in Israel.
That taste of the $1.30's we had today must have felt horrible for most until we came back some. Well don't feel so relieved. There were a lot of U.S. buyers recently that would have no problem cutting losses and chalk it up to a lesson learned when it comes to the twins. And I'm sure the Israeli investors are happy with a 15% haircut. They know this is their last raise without an unbelievable dilution. That is why the secretive ATM disclosure from the end of the quarter to the release of the quarter. Better get it while you can management...cause this is your last chance!!!
I have never wanted to be wrong more in my life. If I am, feel free to attack and make fun of me as much as you want. I will gladly put my tail between my legs, and bow down to the cheerleaders on this board. Nothing I would love more.
I'm not really one who looks for advice in most situations. I am quite confident in my abilities to figure things out using grey matter and resources readily available to people in this day and age. But thanks though.
I don't worry about the day to day fluctuations in this stock. I have been here for many years and have seen this drift down many times before. You were buying 30,000 shares soon after the raise. A small haircut right now, but if history repeats itself, we should hit the $1.20's if that happens, hopefully it was just a case of exaggerated bravado on the purchasing for your sake. But if you didn't actually pull the trigger and we hit the $1.20's, an advanced "your welcome." You claimed you've seen raises and prices go back up after with other companies. But you haven't watched this company long enough. I don't like to just sit back and relax. I like to think of potential scenarios etc to help me decide when or if to pull the trigger. Not that it's helped me in this stock, I begrudgingly admit.
But I do worry about dilution. This is what we have had of late.
January...12.2 million shares
Q3...4 million share gift to the twins
October...13.5 million shares and 830,000 from ATM
Grand total...29.7 million shares.
So for them to dilute shares by what, 30 to 35 percent this year alone is a concern to me. I would think it would be a concern for most. This dilution bought is approximately 5 quarters of keeping our lights on. Obviously necessary, but still a concern.
I will be my good old backseat CEO for a moment. Do you not think making a deal with larger pharma on one of our product candidates would have been a better route to go. Yes not a great deal like management may want, but one that enables us to have a substantial increase in non dilutive cash. Bow down and get a deal done closer on their terms. They're big dogs for a reason. Having a large pharma backing us, would bring instant credibility to this company. Would also bring about the vast knowledge and resources that come from this type of company, especially when it comes to clinical trials.
We do after all, have countless other indications that this technology may be able to help. Some argue that once a deal is done at a lower price, hard to move up. Don't think that's the case at all. Just the circumstance alone is easily justified. But if a company is offered something that will add to their bottom line, why would they refuse? If they do, others won't. Someone came up to me and offered me a percentage of profits that would give me 10, 20, 30 percent (whatever that number would be) I would be foolish not to at least take a serious look at it.
Now let's take a little closer look at these trade shows. What industry did Zami come from? Elbit vision systems. See this type of product makes sense for trade shows. You have a product you want to sell, show it to the masses in shows related to your product. Marketing for something to actually market.
Now the shows we go to what, give you 20 to 30 minutes to present your clinical trial advances, or the 3D bioreactor that you can't buy or use? Anyone watch one of Karine's presentations at one of these things? Yawn. Sorry don't see the value in it. But it seems that Zami sure does. That's where he came from, being able to come back standing tall and say we sold x amount of widgets. Don't think there is much value to any of this. Clinical trial results peak big pharma interest of the serious kind. Anyone who is interested in Pluristem's product, is already aware of anything anyone would say at one of these things. A simple phone call or a few clicks on the keyboard, and the doors are open.
I understand that this is the norm. Under normal circumstances I could justify it as a cost of doing business. A little marketing expense, to help with your name. But to be within 8 months of having the lights turn down, at least in 3/4 of the office while the cost cutting contingency plan comes into place, is unjustified beyond belief. This is where the appropriate jet setting stereotypical comment stem from. Lets book even more of them. Don't recall ever seeing so many as I have right now. Rubs shareholders the wrong way, wasteful use of existing, ever dwindling cash on hand.
So this product doesn't worry me in the least. Management is THE worry. Wrong people running this company, and pushing ever closer to the "year of the shareholder" being postponed for yet another year. If nothing happens by year end, heads should roll. And if nothing happens by year end, our price will be at a point where it might piss people off who have a voice to make it happen. Think I'm tough on management now? Trust me I will be relentless come the last trading day of 2017 and sitting in the $1.20's or lower.
Does anyone actually make it to the end of my posts? LMBO!!!
That's better thanks. I don't like falsehood and saying that is incorrect.
Now you're sounding like Allo again unfortunately. By this, I am assuming you are meaning R18, or else why would you care about fire under someone's ass unless that's what you like. I just said earlier, why, if they really wanted this so badly, would they just not have started the trial immediately? Give them $40 mil development costs and get it going. Would have been nearing completion by now. But to do this round about way to get their hands on R18 seems illogical to me.
But you know, there's still no way you can say 100% sorry. That's your example not theirs. Say 99% could care less. 100% makes it false.
If they wanted it sooooooo bad like you think, wouldn't it have just been easier to start the trial right after dosing was done. Much easier and way less bureaucracy. But when your ideas don't come to fruition like most times, you switch to some crazy scheme. All one big front to get R18. Just like Lonza theory. LMBO
It hurts allright...going to have to switch to another body part to laugh off
Hey EichKing I share in your pessimistic views of this company. Not all roses by any means. But a contract either for funding or stockpiling for ARS is a distinct possibility. Don't think it will happen this year, but hoping for an early Christmas present on that one.
If we don't get something started on ARS pivotal trial this year or first quarter latest next year, dilution will come again soon after. Obviously a partnership or something else would change that as well.
The grant covers a significant portion of the CLI trial, but not all. And with Pluristem directly only receiving $3.4 million directly, doesn't keep us afloat much longer. And I can't, based on previous trials etc., see this trial moving quickly.
I believe so much of the future of this company, or stock price and future dilution concerns at least, rests entirely on ARS. I am astonished it has taken this long already. But if the U.S. wants it, budget or no budget they will get it.
Just further proof of the reason this raise was done. Costs will be rising and need the cash to keep it sustainable.
Not sure I agree with knowing what's happening with this bill being voted on, but totally agree on the use of the money raised. No hidden agendas there that's for sure.
The chances of someone outside of management or government knowing this for sure? Zero!!! LMAO!!! Communications between 2 different governmental departments can be challenging to say the least. But now throw in what is in essence a foreign company, and those chances diminish.
Not saying there's not a chance, just see zero factual evidence to justify that number. Those numbers are usually reserved for the eternal optimistic one. LMAO
After looking at the results from the quarter, it is clearly evident WHY they did this raise. The obvious need for cash. Hopefully you can make it to the end as its a long one.
Looking at the numbers, as of Sept 30th, they had $18 million of working capital left, and that's including the sales stated from the ATM. Now their cash used for operating activities was $5.2 million.
Now during this quarter, they received $1.3 million from the IIA grant (Israeli government grant) I'm no accountant and maybe someone could clarify, but wouldn't their burn rate be $6.5 million a quarter then? If it is the latter, that's 3 quarters of operating cash left. Even using the smaller number, buys a little more time.
Now before you all yell about our three grants news releases in which we saw $26 million in grant money, numbers are in this quarter. I seem to remember seeing one of the following before. But may have just thought it was the collaborative grant. But we get numbers for all three and direct amount of money coming to Pluristem for manufacturing and other costs.
August 2016 CLI Horizon grant of $9 million...originally $3.4 million directly to us.
Sept 2017 femur neck fracture Horizon grant of $8.7 million...$2.8 million directly to us.
Oct 2017 nTrack collaborative grant of $8 million...$600,000 directly to us.
So if you look at the highly praised $26 million in total, we are actually only getting $6.8 million. I'm not knocking these grants in any way, and yes they will indirectly save us money on the costs of these trials. But these are savings on increasing costs associated with the trials themselves. Has no impact on our burn rate.
Everyone knew the third grant was a collaborative grant. Did anyone else realize the first two were as well. I didn't. Don't think others did as well as this $26 million was thrown around before when talking about how long this company can survive. I took a look at the previous two they used the word consortium. A little different term, but didn't give the sense of grant sharing imo.
But to throw out tweets bragging about $28 million in grant money, is pretty deceptive to say the least. Wouldn't call it transparent, that's for sure. But in all fairness, I did go to the year end and saw one of them there with theses numbers.
Now let's include the raise. $13.7 million, bringing us to $31.7 million. Even at an even $5 million a quarter burn, that brings us to just over 6 quarters. Use the $6.5 million burn rate, and that's under 5. Hopefully someone will confirm as a quarter difference is a huge difference. And that's providing no increase. We can add a quarter as well for the grant money, but when that money comes in, would be a factor. And I seem to recall some already booked previously.
So even at the best case, 7 quarters, that brings us to 2q19. Not quite the 4q19, but contingency plan is there for that.
So if you look at it pre raise and ATM, we were within 9 months of running out of cash. 9 months!!!
They didn't give numbers for the ATM from end of quarter to release date, like they did at year end. A little odd to change the way you release things from one quarter to the next, unless there was none sold of course. Now after coming within 9 months of cash, I hope they did actually reap the substantially higher prices they could have gotten via the ATM after Sept 30th. Heck kind of wish Allo and his $80 million projection was right. Still could be theoretically I guess. We will just have to wait another 3 months to find out. Again transparency is lacking severely.
I'm looking forward to the shareholder update, considering all that has transpired. November presentation should come any day now.
Sorry for the lengthy post, Like always, some free DD for all to see, and I hope it was alright. Tried not to be repetitive too much.
Grasping at straws now aren't you. No "if" in that first sentence is there. You could have also used you werent talking about pluristem as you didn't mention their name in that same sentence. Just a suggestion for next time.
Post 7842, since you don't see the reply to. Go back and see if it jogs someone's memory. Give em crap!!! I told you it's not just one!!! OPA!!! Ya I'm lying.
No sorry you clearly said they sold $80 million. Not only that, you throw in maybe it was to partner with the U.S. Government. And throw in some useless link to try and show there's hope EH? Ta right. It's right there in your post I'm replying to.
I guess it's hard to keep track of what others are posting on your days off. Or even across the cubicles for that matter. Oh sorry i forgot. Are you guys home based now since the midnight move several years ago? OPA!!!!
One thing I would like to say is I have no idea where this share price will be today, tomorrow or anytime. I have stated we may drift down to the $1.30's in the next month. That is my opinion only. We could burst through $2 tomorrow. Not here to sway anyone's opinion in any decision they make. Only want to show possibilities, concerns, etc. And of course to hold management responsible for their endless, empty promised milestones.
When we popped above $2, then went to the $1.90's, many were bragging/preaching it was a great time to buy more or open up a position. Look at it now. Must be an astounding opportunity now that we are down close around 40% from that time. But yes it could be a great time who knows. Some here have a vested interest in what they post. Do your own DD, and make decisions on what is best for you. Even the most enthusiastic one here can post some good links on occasion, but once they add commentary to the equation, that's where it goes downhill. Usually it is full of plausible, yet highly unlikely speculation, and sometime outright lies.
There's a lot of sells under 300 shares. We have seen this pattern often in our years of drip drip drip. Will it continue? I sure hope not. But if you have watched Pluristem as long as I have, it is a distinct possibility. Hopefully we hold at the $1.50 range, or I think the chances of us hitting the $1.30's becomes a bigger possibility. That $1.50 mark will be a significant psychological number. And we are inching ever so near. And if our volume dries up more like it has been, it will be easier for them to accomplish what they are trying to do.
Give us some news with teeth please!!!
It is impossible to answer that question. They could have. I doubt it, but with the volume we had in our latest run, theoretically possible. A majority of shares would have had to been sold by them. Only people who know are management. I used to think the three firms would know, but they would only know what they sold. One thing IS for sure, they didn't sell $80 million worth of stock and diluted only 10 million shares. THAT, would be impossible. Yet some believe it true. At least one, maybe twozz.
So you love their DD and enthusiasm. Wouldn't have expected anything less. Their daily rehashing of old news, searches on clinical trials daily, to let us know a new site opened up. Article after article of things with often little to no relevance to Pluristem. Their seven plus years of saying "this will be the week". I love it too!!! Lmao
And what happens when some actual thoughts get posted. Maybe you can weigh in on some of their thoughts. I am just posting a some I can remember in the last few weeks, but there are hundreds just like it. I should actually make a greatest hits list.
I guess you belieb, that Pluristem raised $80 plus million, yet diluted only 10 million? Or even that they raised $80 million which is now stated because the original comment is so absurd.
I guess you belieb, big pharma is controlling our price.
I guess you belieb, Pluristem was selling, to support their share price.
I guess you belieb, that they have a major announcement coming from Lonza's desire to have us be their customer.
I guess you belieb, Pluristem injected all 172 patients in the IC trial with PLX PAD, even though there was a placebo group. Last I checked placebo meant fake.
I guess you belieb, the many proven false claims they have made.
Yes I would think they have great DD as well. If I was blinded like some are. Can't wait to see if you believe like they believe. I will anxiously await your thoughts on the topics I brought up. One by one please.
I called them out a couple months ago later in the night on who they were on a different board. What happened next? Within 5 minutes, ALL their posts were deleted. Boiler room 101. You are caught in an awkward position where you're not sure what to do and can't get an answer from higher up right away. Delete your posts.
But you keep beliebing them. There's a difference between enthusiasm and putting out false statements to suit whatever their end game is. Sorry some don't see it. Sand has scratched out too many eyeballs I guess. And let me guess...you're a Trump supporter
Run lovers run. LMAOxAgabillion cause I'm not asking for or wanting your trust. You're a belieber
Hey Stox. I have stated previously my position, but here it is again. I used to have a sizeable long position in Pluristem at least for me, for at least 6 years. It could be longer. Think it was within the first year that they did the R/S. I had to sell last year as I needed the cash, but didn't want to risk missing a big announcement. My timeframes may be off a little, as time really has become a blur for me with this company.
That's when I switched to options. Decided if I put a quarter of what I sold in the farthest dated $2 options, then I could buy approximately 2 years of time. If we hit $3+ at any point, I would be farther ahead than if I owned shared. I am 2 sets expired and my third will expire in March. Will still have one quarter of my original money and won't put that amount in until my March ones are closer. The interest in these options has increased significantly. Almost of my $2's were bought for a nickel. I did buy a little more for a quarter. I did buy a small amount of Dec 2's, as I could still get them cheap but with way more risk. I have bought some $1's before as well, and did quite well on them.
If we do happen to get a significant run in price, I would sell the options and buy back shares, or continue with options, depending on price and news out. These options hit 40 cents at one point. A substantial gain but not nearly what I'm hoping for.
To be quite honest I have no idea where we will be in six months. I do think there's a good chance we will hit the $1.30's range in the next month. Closing Sosei will do jack for the price imo. If we do drop, I'll buy more $2 options as well, for June or even later if they open up.
This run was feeling so different than any for a long time then bam, the raise. I don't have too much faith in the management as you obviously know. And I'm not sure Tutes do either. And I think there were many of them buying via the ATM, and now they got shafted.
It just baffles me how we are where we are. I do think this stock is pretty manipulated. If for no reason except for our price versus the unbelievable potential. And news does nothing at all for many years. It was a nice change of late to see news do something positive to the price, but again, that was just manipulation most likely by the 3 firms hired. They did their job well as I have said in the past. But this is not big pharma manipulating, like someone here believes.
Im truly just hoping we hit $5 in the next 6 months, as we did hit that once. And that would mean around a half billion market cap. Not unrealistic for this company, by any means. That would mean an almost 60 bagger for me less commissions. But anything over $3 and I will be very happy.